基于combretastatin A-4的化合物作为潜在的抗癌药物:一篇评论
Mai H Omar1, Soha H Emam1, Demiana S Mikhail1
1Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
Bioorganic chemistry
|November 6, 2024
概括
康布雷塔斯坦A-4 (CA-4) 类型是癌症治疗中微管向药物的关键. 最近的进展侧重于通过创新的设计策略和双重定位方法来克服临床限制,以提高疗效.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 康布雷塔他丁A-4 (CA-4) 是一种具有显著细胞毒性活性的强效天然产品,作为微管向剂的化合物.
- 微管向剂在癌症化疗中至关重要,但耐药性和毒性仍然是挑战.
- 最近的研究 (2016-2023) 探索了新的CA-4类似物,以提高抗癌疗效和克服局限性.
研究的目的:
- 为从2016年到2023年初的CA-4模拟发展提供全面的时间概述.
- 讨论设计策略,结构-活动关系,合成和有前途的CA-4类型的结合相互作用.
- 突出这些类型的抗癌潜力和临床应用局限性,建议改进策略.
主要方法:
- 文献综述侧重于2016年至2023年初之间开发的CA-4类别.
- 分析设计策略,结构-活动关系和合成途径.
- 评估细胞毒性活性,结合相互作用和生物抗癌活性.
主要成果:
- 已经合成和评估了许多具有多种结构修饰的CA-4类似物.
- 双向性图林抑制剂显示出克服药物耐药性和增强协同效能的潜力.
- 将CA-4类似物与 (IV),氨基酸,HDAC抑制剂,亚丁-2-,醇,硫化物或原子等部分结合在一起,产生了强大的化合物.
结论:
- CA-4类似物代表了一类具有不同作用机制的有前途的抗癌药物.
- 创新策略,包括双重向和与其他治疗组合的结合,对于提高疗效和克服耐药性至关重要.
- 对CA-4类别的进一步研究具有促进癌症化疗的巨大潜力.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.5K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
